am 251 has been researched along with Autosomal Dominant Striatonigral Degeneration in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, MDC | 1 |
| Ashraf, NS | 1 |
| Fischer, S | 1 |
| Yang, Y | 1 |
| Schapka, E | 1 |
| Joshi, G | 1 |
| McQuade, TJ | 1 |
| Dharia, RM | 1 |
| Dulchavsky, M | 1 |
| Ouyang, M | 1 |
| Cook, D | 1 |
| Sun, D | 1 |
| Larsen, MJ | 1 |
| Gestwicki, JE | 1 |
| Todi, SV | 1 |
| Ivanova, MI | 1 |
| Paulson, HL | 1 |
1 other study available for am 251 and Autosomal Dominant Striatonigral Degeneration
| Article | Year |
|---|---|
Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.
Topics: Animals; Animals, Genetically Modified; Antipsychotic Agents; Aripiprazole; Ataxin-3; Brain; Disease | 2016 |